Friday, March 1st, 2024, 12:05-12:25pm ET
Advances in Basal Insulin: Practical uses from a Clinician’s Perspective
Novella (Breakout Room)
At the end of this session, attendees will be able to:
- Discuss the practical aspects of managing innovative basal insulin for patients with type 2 diabetes
- Differentiate the clinical challenges and advantages between basal insulin options for treatment of type 2 diabetes
Dr. Jonathan Vecchiarelli MD FRCPC
LMC Diabetes and Endocrinology
This non-accredited, industry sponsored symposium is brought to you by
Friday, March 1st, 2024, 12:40-1:00pm ET
Changing the Story of Type 1 Diabetes
Novella (Breakout Room)
This session will focus on Type 1 Diabetes (T1D) as an autoimmune disorder, delving into its effects on beta cells. Exploring different screening goals and the role of screening in identifying people at risk. Furthermore, we’ll spotlight clinical research initiatives aimed at safeguarding beta cell function and impeding disease advancement.
Dr. Bruce A. Perkins MD MPH FRCP(C)
Professor of Medicine and Clinician-Scientist, University of Toronto
The Sam and Judy Pencer Family Chair in Diabetes
Director of the Diabetes Clinical Research Unit, Sinai Health System
This non-accredited, industry sponsored symposium is brought to you by
